J&J | Spese Operative

Operating Expenses Cambiamento Data
AstraZeneca USD 9.54B 578M 2023-09
Bayer EUR 13.94B 1.94B 2023-09
Cooper Companies USD 791.4M 12.8M 2023-09
Gilead Sciences USD 5.5B 1.08B 2023-12
Insulet USD 403.4M 25.5M 2023-12
Roche Holding CHF 20.02B 5.04B 2023-06
Teva Pharmaceutical Industries USD 3.5B 1.03B 2023-09



J&J Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.